A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Condition:   HIV-1-infection Interventions:   Biological: Vaccine and vedolizumab (Entyvio);   Biological: Placebo vaccine and vedolizumab infusion (Entyvio);   Biological: Placebo vaccine and placebo infusion Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   EuroVacc Foundation;   European AIDS Treatment Group (EATG);   Medical Research Council;   University College London, UK.;   University of L iverpool;   Erasmus Medical Center;   Henri Mondor University Hospital;   European Georges Pompidou Hospital;   Saint-Louis Hospital, Paris, France;   Centre Hospitalier Universitaire Vaudois;   Chelsea and Westminster Hospital, UK;   Universitätsklinikum Hamburg-Eppendorf ;   Hospital Clinic of Barcelona;   Istituto Nazionale Malattie Infettive Lazaro Spallanzani;   Imperial College London;   Institut d'Investigacions Biomèdiques August Pi i Sunyer;   European Commission;   Swiss Government Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials